Surgical Oncology, Nebraska Medicine

Medicine & Life Sciences

1. Pancreatic Neoplasms 100%
2. Peritoneal Neoplasms 76%
3. Adenocarcinoma 57%
4. Neoplasms 57%
5. Oncologists 48%
6. Peritoneal Diseases 45%
7. Guidelines 43%
8. Neoplasm Metastasis 37%
9. Cytoreduction Surgical Procedures 34%
10. Induced Hyperthermia 29%
11. Surgeons 28%
12. gemcitabine 28%
13. Survival 24%
14. Pancreaticoduodenectomy 24%
15. Palliative Care 22%
16. Pathologists 20%
17. Breast 20%
18. Pharmacists 20%
19. Radiologists 18%
20. Therapeutics 18%
21. Neuroendocrine Tumors 18%
22. Fluorescence 17%
23. Physicians 16%
24. Neoadjuvant Therapy 15%
25. Appendiceal Neoplasms 15%
26. Pancreatic Ducts 15%
27. Drug Therapy 15%
28. Surgical Oncology 14%
29. Pancreatic Fistula 14%
30. Breast Neoplasms 14%
31. Colorectal Neoplasms 14%
32. Pseudomyxoma Peritonei 14%
33. Mutation 13%
34. Nanoparticles 13%
35. Margins of Excision 13%
36. Segmental Mastectomy 13%
37. Thyroidectomy 13%
38. Primary Hyperparathyroidism 12%
39. Trefoil Factor-2 12%
40. Indocyanine Green 11%
41. Stomach Neoplasms 11%
42. Mortality 11%
43. Recurrence 11%
44. Pancreatectomy 10%
45. IRDye800 10%
46. Hyaluronic Acid 10%
47. Practice Guidelines 10%
48. Nelfinavir 10%
49. Morbidity 10%
50. Mastectomy 10%
51. Liver 10%
52. Radiosurgery 10%
53. Melanoma 10%
54. Niclosamide 10%
55. Mucins 10%
56. Radiotherapy 10%
57. Desmoplastic Small Round Cell Tumor 9%
58. Pancreas 9%
59. Thyroid Neoplasms 9%
60. Parathyroid Neoplasms 9%
61. Databases 9%
62. Ovarian Neoplasms 8%
63. Tumor Microenvironment 8%
64. Cefoxitin 8%
65. Length of Stay 8%
66. Cancer-Associated Fibroblasts 8%
67. Mesothelioma 8%
68. Thyroid Gland 8%
69. Esophagogastric Junction 7%
70. Circulating Neoplastic Cells 7%
71. Nomograms 7%
72. Gastrointestinal Stromal Tumors 7%
73. Stomach 7%
74. Basal Cell Carcinoma 7%
75. Germ-Line Mutation 7%
76. Surgical Wound Infection 7%
77. Tazobactam Drug Combination Piperacillin 7%
78. Standard of Care 6%
79. Colectomy 6%
80. Computer-Assisted Surgery 6%
81. Biomarkers 6%
82. Pandemics 6%
83. Ferrosoferric Oxide 6%
84. Clinical Trials 6%
85. Neoplastic Stem Cells 6%
86. oregovomab 6%
87. General Hospitals 6%
88. Heterografts 6%
89. Thyroid Hormones 6%
90. Pathology 6%
91. Trefoil Factor-1 6%
92. Esophagectomy 5%
93. Parathyroidectomy 5%
94. Splenic Neoplasms 5%
95. Drainage 5%
96. Epigenomics 5%
97. Lymph Nodes 5%
98. Geranyltranstransferase 5%
99. Colonic Neoplasms 5%